Executive Committee
The Stanford Center for Excellence in Pulmonary Biology
Director
David Cornfield, MD
A physician scientist, Dr. Cornfield is actively engaged in clinical medicine, teaching and research. In clinical arena, Dr. Cornfield is a Pediatrician with an active practice in both Pediatric Pulmonary Medicine and Pediatric Critical Care Medicine. In the research arena, Dr. Cornfield's lab addresses several large thematic issues. The areas of concentration include: (i) regulation of pulmonary vascular tone; (ii) oxygen sensing in the lung; (iii) biological determinants of preterm labor focusing on myometrial smooth muscle cells; (iv) developmental regulation of barrier function in the lung; and (v) the role of hypoxia-inducible factor-1 in lung development. In addition, there is an active translational research component.
Basic Research Director
Cristina Maria Alvira, MD
Dr. Alvira is an Assistant Professor of Pediatrics in the Division of Critical Care Medicine. She completed her clinical fellowship in critical care medicine in 2005, and subsequently pursued postdoctoral fellowship training in pulmonary vascular biology under the mentorship of Dr. Marlene Rabinovitch. She was recruited to Stanford School of Medicine Faculty in 2011, and developed an NIH funded independent research program focused on the identification of novel mechanisms that direct alveolar and vascular development during postnatal lung growth. She is an active member of the Pedaitric Academic Society, serves as an Editoral Board Member of the American Journal of Physiology Lung Cellular and Molecular Physiology, and is currently one of the Stanford Child Health Institute's Tashia and John Morgridge Faculty Scholar in Translational Medicine.
Clinical Research Director
Carlos Milla, MD
My research interests have centered on the inflammatory responses that lead to airway disease in Cystic Fibrosis (CF) and the metabolic factors that contribute to CF lung disease progression. Current efforts are focused on the understanding of the early events that drive the development of lung disease through the study of infants with CF identified by newborn screening. This includes the development of new diagnostic tools that permit the early detection of lung disease manifestations.
Director Emeritus
Richard Moss, MD
Dr. Moss has conducted lung-based basic, translational and clinical research for over 40 years. He led the pediatric pulmonary research group from 1991 to 2006, and joined the first cohort of the Cystic Fibrosis Foundation’s Therapeutics Development Network in 1998, serving as the first Chair of its protocol Review Committee. Dr Moss directed the Ross Mosier Laboratory for CF Research at Stanford for 25 years until 2005. He was the first Co-Director of Stanford’s Children’s Health Research Program; with Stanford’s Clinical and Translational Science Award from the National Institutes of Health he became a member of the Spectrum Child Health Executive Committee.
Faculty and Staff
The Stanford Center for Excellence in Pulmonary Biology